Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system... Show more
Be on the lookout for a price bounce soon.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMIX's RSI Oscillator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMIX advanced for three days, in of 61 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on September 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AMIX as a result. In of 20 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AMIX turned negative on September 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AMIX broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMIX entered a downward trend on September 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.887) is normal, around the industry mean (60.117). P/E Ratio (0.000) is within average values for comparable stocks, (36.948). AMIX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.680). AMIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.000) is also within normal values, averaging (79.117).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AMIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor tells us that AMIX and SERA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMIX and SERA's prices will move in lockstep.
Ticker / NAME | Correlation To AMIX | 1D Price Change % | ||
---|---|---|---|---|
AMIX | 100% | +1.94% | ||
SERA - AMIX | 28% Poorly correlated | +4.75% | ||
VAPO - AMIX | 24% Poorly correlated | N/A | ||
ELUT - AMIX | 20% Poorly correlated | -3.67% | ||
TLSI - AMIX | 10% Poorly correlated | -1.26% | ||
SSII - AMIX | 10% Poorly correlated | -1.59% | ||
More |
Ticker / NAME | Correlation To AMIX | 1D Price Change % |
---|---|---|
AMIX | 100% | +1.94% |
Health Services category (438 stocks) | 11% Poorly correlated | +0.41% |
Medical/Nursing Services category (226 stocks) | 5% Poorly correlated | -0.24% |